Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,583 | Dovepress* | 8,027+ | 801 | 8,828 | |
PubMed Central* | 556 | 242 | 798 | ||
Totals | 8,583 | 1,043 | 9,626 | ||
*Since 19 September 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed and Google Scholar